AKEBIA THERAPEUTICS, INC. Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
AKEBIA THERAPEUTICS, INC. (AKBA) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-02-26
- AKEBIA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2025 was $0.00.
- AKEBIA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- AKEBIA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2023 was $2.70M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2023-12-31 | $2.70M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |